Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  January 6, 2025
Memoranda
2025 Forecast for U.S. Federal and International Chemical Regulatory Policy

Bergeson & Campbell, P.C. (B&C®), its global consulting affiliate The Acta Group (Acta®), and consortia management affiliate B&C®...

  July 22, 2024
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  January 28, 2025
Memoranda
EPA Releases Draft Scope Document for Vinyl Chloride TSCA Risk Evaluation

On January 16, 2025, the U.S. Environmental Protection Agency (EPA) announced the availability of and requested public comment on the draft scope of...

  January 27, 2025
Memoranda
EPA Proposes Risk Management Rule to Protect Workers from Inhalation Exposure to PV29

On January 14, 2025, the U.S. Environmental Protection Agency (EPA) issued a proposed rule to address the unreasonable risk of injury to human health...

  January 17, 2025
Memoranda
EPA Releases Final Risk Evaluation for DINP, Finding Unreasonable Risk of Injury to Human Health When Workers Are Exposed under Four COUs

On January 14, 2025, the U.S. Environmental Protection Agency (EPA) released the final risk evaluation for diisononyl phthalate (DINP) conducted under...

  January 15, 2025
Memoranda
EPA and OSHA Sign MOU for Implementation of TSCA Section 6

The U.S. Environmental Protection Agency (EPA) announced on January 13, 2025, that it signed a long-awaited memorandum of understanding (MOU) with the...

  December 31, 2024
Memoranda
Maine Proposes Rule Regarding Products Containing Intentionally Added PFAS

On December 20, 2024, the Maine Department of Environmental Protection (MDEP) published a proposed rule regarding products containing intentionally...

Seminars & Webinars

  December 20, 2024
Seminars & Webinars
Environmental Law 2025: Tackling the Issues in a Pivotal Year, February 20 – 21, 2025, Washington, D.C. and via webcast

ALI CLE presents “Environmental Law 2025: Tackling the Issues in a Pivotal Year,” a two-day program on what lies ahead in a pivotal year for...

  December 20, 2024
Seminars & Webinars
TSCA Developments 2025, February 27, 2025, via webinar

Chemical Watch presents TSCA Developments 2025, covering TSCA and its business-critical implications, including TSCA inventory updates, risk...

  December 20, 2024
Seminars & Webinars
The PFAS Playbook: Strategies to Minimize Regulatory and Commercial Risk, March 11, 2025, 12:00 p.m. – 1:00 p.m. (EST)

ALI CLE presents “The PFAS Playbook: Strategies to Minimize Regulatory and Commercial Risk.” This comprehensive course, taught by Lynn L....

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, six Ph.D.’s. Government affairs and regulatory specialists including five high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.